Everpar Advisors LLC Natera, Inc. Transaction History
Everpar Advisors LLC
- $188 Billion
- Q1 2025
A detailed history of Everpar Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Everpar Advisors LLC holds 1,558 shares of NTRA stock, worth $262,133. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,558
Previous 1,719
9.37%
Holding current value
$262,133
Previous $272 Million
19.04%
% of portfolio
0.12%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding NTRA
# of Institutions
651Shares Held
126MCall Options Held
975KPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA12.4MShares$2.09 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.77 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.24 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$765 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...